Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-06-05
1998-06-30
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514357, 514419, 544168, 546334, 548496, A61K 31535, A61K 3140, C07D26528, C07D20732
Patent
active
057734380
ABSTRACT:
Synthetic mammalian matrix metalloprotease inhibitors are disclosed that are useful for treating or preventing diseases wherein said diseases are caused by unwanted mammalian matrix metalloprotease activity and include skin disorders, keratoconus, restenosis, rheumatoid arthritis, wounds, cancer, angiogenesis and shock.
REFERENCES:
patent: 4558034 (1985-12-01), Galardy et al.
patent: 4599361 (1986-07-01), Dickens et al.
patent: 4743587 (1988-05-01), Dickens et al.
patent: 4996358 (1991-02-01), Handa et al.
patent: 5304604 (1994-04-01), Davidson et al.
patent: 5453438 (1995-09-01), Campion et al.
Galardy Richard E.
Grobelny Damian
Holme Kevin R.
Levy Daniel E.
Musser John H.
Glycomed Incorporated
McKane Joseph
The University of Florida
LandOfFree
Synthetic matrix metalloprotease inhibitors and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic matrix metalloprotease inhibitors and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic matrix metalloprotease inhibitors and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1859507